CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
Market Analysis and Insights: Global CAR T-Cell Immunotherapy Market
The global CAR T-Cell Immunotherapy market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global CAR T-Cell Immunotherapy Scope and Segment
The global CAR T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Monotherapy
Combination Therapy
By the application, this report covers the following segments
Hematologic Malignancies
Solid Malignancies
Competitive Landscape:
The CAR T-Cell Immunotherapy key manufacturers in this market include:
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Market Analysis and Insights: Global CAR T-Cell Immunotherapy Market
The global CAR T-Cell Immunotherapy market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global CAR T-Cell Immunotherapy Scope and Segment
The global CAR T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Monotherapy
Combination Therapy
By the application, this report covers the following segments
Hematologic Malignancies
Solid Malignancies
Competitive Landscape:
The CAR T-Cell Immunotherapy key manufacturers in this market include:
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
1 Market Overview of CAR T-Cell Immunotherapy
1.1 CAR T-Cell Immunotherapy Market Overview
1.1.1 CAR T-Cell Immunotherapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global CAR T-Cell Immunotherapy Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global CAR T-Cell Immunotherapy Market Size by Region (2015-2026)
1.4 Global CAR T-Cell Immunotherapy Historic Market Size by Region (2015-2020)
1.5 Global CAR T-Cell Immunotherapy Market Size Forecast by Region (2021-2026)
1.6 Key Regions, CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.1 North America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.2 Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.3 China CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.5 Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
2 CAR T-Cell Immunotherapy Market Overview by Type
2.1 Global CAR T-Cell Immunotherapy Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
2.3 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)
2.4 Monotherapy
2.5 Combination Therapy
3 CAR T-Cell Immunotherapy Market Overview by Application
3.1 Global CAR T-Cell Immunotherapy Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2015-2020)
3.3 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)
3.4 Hematologic Malignancies
3.5 Solid Malignancies
4 Global CAR T-Cell Immunotherapy Competition Analysis by Players
4.1 Global CAR T-Cell Immunotherapy Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019)
4.3 Date of Key Manufacturers Enter into CAR T-Cell Immunotherapy Market
4.4 Global Top Players CAR T-Cell Immunotherapy Headquarters and Area Served
4.5 Key Players CAR T-Cell Immunotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 CAR T-Cell Immunotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business and Company’s Total Revenue
5.1.3 AbbVie Products, Services and Solutions
5.1.4 AbbVie Revenue (US$ Million) (2015-2020)
5.1.5 AbbVie Recent Development and Reaction to Covid-19
5.2 Celgene
5.2.1 Celgene Profile
5.2.2 Celgene Main Business and Company’s Total Revenue
5.2.3 Celgene Products, Services and Solutions
5.2.4 Celgene Revenue (US$ Million) (2015-2020)
5.2.5 Celgene Recent Development and Reaction to Covid-19
5.3 Kite Pharma
5.5.1 Kite Pharma Profile
5.3.2 Kite Pharma Main Business and Company’s Total Revenue
5.3.3 Kite Pharma Products, Services and Solutions
5.3.4 Kite Pharma Revenue (US$ Million) (2015-2020)
5.3.5 Oxford BioMedica Recent Development and Reaction to Covid-19
5.4 Oxford BioMedica
5.4.1 Oxford BioMedica Profile
5.4.2 Oxford BioMedica Main Business and Company’s Total Revenue
5.4.3 Oxford BioMedica Products, Services and Solutions
5.4.4 Oxford BioMedica Revenue (US$ Million) (2015-2020)
5.4.5 Oxford BioMedica Recent Development and Reaction to Covid-19
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business and Company’s Total Revenue
5.5.3 Novartis Products, Services and Solutions
5.5.4 Novartis Revenue (US$ Million) (2015-2020)
5.5.5 Novartis Recent Development and Reaction to Covid-19
5.6 Gilead
5.6.1 Gilead Profile
5.6.2 Gilead Main Business and Company’s Total Revenue
5.6.3 Gilead Products, Services and Solutions
5.6.4 Gilead Revenue (US$ Million) (2015-2020)
5.6.5 Gilead Recent Development and Reaction to Covid-19
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business and Company’s Total Revenue
5.7.3 Pfizer Products, Services and Solutions
5.7.4 Pfizer Revenue (US$ Million) (2015-2020)
5.7.5 Pfizer Recent Development and Reaction to Covid-19
5.8 Cellectis
5.8.1 Cellectis Profile
5.8.2 Cellectis Main Business and Company’s Total Revenue
5.8.3 Cellectis Products, Services and Solutions
5.8.4 Cellectis Revenue (US$ Million) (2015-2020)
5.8.5 Cellectis Recent Development and Reaction to Covid-19
5.9 Bellicum
5.9.1 Bellicum Profile
5.9.2 Bellicum Main Business and Company’s Total Revenue
5.9.3 Bellicum Products, Services and Solutions
5.9.4 Bellicum Revenue (US$ Million) (2015-2020)
5.9.5 Bellicum Recent Development and Reaction to Covid-19
5.10 Mustang Bio
5.10.1 Mustang Bio Profile
5.10.2 Mustang Bio Main Business and Company’s Total Revenue
5.10.3 Mustang Bio Products, Services and Solutions
5.10.4 Mustang Bio Revenue (US$ Million) (2015-2020)
5.10.5 Mustang Bio Recent Development and Reaction to Covid-19
5.11 CARsgen Therapeutics
5.11.1 CARsgen Therapeutics Profile
5.11.2 CARsgen Therapeutics Main Business and Company’s Total Revenue
5.11.3 CARsgen Therapeutics Products, Services and Solutions
5.11.4 CARsgen Therapeutics Revenue (US$ Million) (2015-2020)
5.11.5 CARsgen Therapeutics Recent Development and Reaction to Covid-19
5.12 Xyphos
5.12.1 Xyphos Profile
5.12.2 Xyphos Main Business and Company’s Total Revenue
5.12.3 Xyphos Products, Services and Solutions
5.12.4 Xyphos Revenue (US$ Million) (2015-2020)
5.12.5 Xyphos Recent Development and Reaction to Covid-19
5.13 Minerva Biotechnologies
5.13.1 Minerva Biotechnologies Profile
5.13.2 Minerva Biotechnologies Main Business and Company’s Total Revenue
5.13.3 Minerva Biotechnologies Products, Services and Solutions
5.13.4 Minerva Biotechnologies Revenue (US$ Million) (2015-2020)
5.13.5 Minerva Biotechnologies Recent Development and Reaction to Covid-19
5.14 Adaptimmune
5.14.1 Adaptimmune Profile
5.14.2 Adaptimmune Main Business and Company’s Total Revenue
5.14.3 Adaptimmune Products, Services and Solutions
5.14.4 Adaptimmune Revenue (US$ Million) (2015-2020)
5.14.5 Adaptimmune Recent Development and Reaction to Covid-19
5.15 Ziopharm Oncology
5.15.1 Ziopharm Oncology Profile
5.15.2 Ziopharm Oncology Main Business and Company’s Total Revenue
5.15.3 Ziopharm Oncology Products, Services and Solutions
5.15.4 Ziopharm Oncology Revenue (US$ Million) (2015-2020)
5.15.5 Ziopharm Oncology Recent Development and Reaction to Covid-19
5.16 Aurora Biopharma
5.16.1 Aurora Biopharma Profile
5.16.2 Aurora Biopharma Main Business and Company’s Total Revenue
5.16.3 Aurora Biopharma Products, Services and Solutions
5.16.4 Aurora Biopharma Revenue (US$ Million) (2015-2020)
5.16.5 Aurora Biopharma Recent Development and Reaction to Covid-19
5.17 Creative Biolabs
5.17.1 Creative Biolabs Profile
5.17.2 Creative Biolabs Main Business and Company’s Total Revenue
5.17.3 Creative Biolabs Products, Services and Solutions
5.17.4 Creative Biolabs Revenue (US$ Million) (2015-2020)
5.17.5 Creative Biolabs Recent Development and Reaction to Covid-19
6 North America CAR T-Cell Immunotherapy by Players and by Application
6.1 North America CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
6.2 North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
7 Europe CAR T-Cell Immunotherapy by Players and by Application
7.1 Europe CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
8 China CAR T-Cell Immunotherapy by Players and by Application
8.1 China CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
8.2 China CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
9 Rest of Asia Pacific CAR T-Cell Immunotherapy by Players and by Application
9.1 Rest of Asia Pacific CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
10 Latin America CAR T-Cell Immunotherapy by Players and by Application
10.1 Latin America CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
10.2 Latin America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
11 Middle East & Africa CAR T-Cell Immunotherapy by Players and by Application
11.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
12 CAR T-Cell Immunotherapy Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 CAR T-Cell Immunotherapy Market Overview
1.1.1 CAR T-Cell Immunotherapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global CAR T-Cell Immunotherapy Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global CAR T-Cell Immunotherapy Market Size by Region (2015-2026)
1.4 Global CAR T-Cell Immunotherapy Historic Market Size by Region (2015-2020)
1.5 Global CAR T-Cell Immunotherapy Market Size Forecast by Region (2021-2026)
1.6 Key Regions, CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.1 North America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.2 Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.3 China CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.5 Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2026)
2 CAR T-Cell Immunotherapy Market Overview by Type
2.1 Global CAR T-Cell Immunotherapy Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
2.3 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)
2.4 Monotherapy
2.5 Combination Therapy
3 CAR T-Cell Immunotherapy Market Overview by Application
3.1 Global CAR T-Cell Immunotherapy Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2015-2020)
3.3 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)
3.4 Hematologic Malignancies
3.5 Solid Malignancies
4 Global CAR T-Cell Immunotherapy Competition Analysis by Players
4.1 Global CAR T-Cell Immunotherapy Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019)
4.3 Date of Key Manufacturers Enter into CAR T-Cell Immunotherapy Market
4.4 Global Top Players CAR T-Cell Immunotherapy Headquarters and Area Served
4.5 Key Players CAR T-Cell Immunotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 CAR T-Cell Immunotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business and Company’s Total Revenue
5.1.3 AbbVie Products, Services and Solutions
5.1.4 AbbVie Revenue (US$ Million) (2015-2020)
5.1.5 AbbVie Recent Development and Reaction to Covid-19
5.2 Celgene
5.2.1 Celgene Profile
5.2.2 Celgene Main Business and Company’s Total Revenue
5.2.3 Celgene Products, Services and Solutions
5.2.4 Celgene Revenue (US$ Million) (2015-2020)
5.2.5 Celgene Recent Development and Reaction to Covid-19
5.3 Kite Pharma
5.5.1 Kite Pharma Profile
5.3.2 Kite Pharma Main Business and Company’s Total Revenue
5.3.3 Kite Pharma Products, Services and Solutions
5.3.4 Kite Pharma Revenue (US$ Million) (2015-2020)
5.3.5 Oxford BioMedica Recent Development and Reaction to Covid-19
5.4 Oxford BioMedica
5.4.1 Oxford BioMedica Profile
5.4.2 Oxford BioMedica Main Business and Company’s Total Revenue
5.4.3 Oxford BioMedica Products, Services and Solutions
5.4.4 Oxford BioMedica Revenue (US$ Million) (2015-2020)
5.4.5 Oxford BioMedica Recent Development and Reaction to Covid-19
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business and Company’s Total Revenue
5.5.3 Novartis Products, Services and Solutions
5.5.4 Novartis Revenue (US$ Million) (2015-2020)
5.5.5 Novartis Recent Development and Reaction to Covid-19
5.6 Gilead
5.6.1 Gilead Profile
5.6.2 Gilead Main Business and Company’s Total Revenue
5.6.3 Gilead Products, Services and Solutions
5.6.4 Gilead Revenue (US$ Million) (2015-2020)
5.6.5 Gilead Recent Development and Reaction to Covid-19
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business and Company’s Total Revenue
5.7.3 Pfizer Products, Services and Solutions
5.7.4 Pfizer Revenue (US$ Million) (2015-2020)
5.7.5 Pfizer Recent Development and Reaction to Covid-19
5.8 Cellectis
5.8.1 Cellectis Profile
5.8.2 Cellectis Main Business and Company’s Total Revenue
5.8.3 Cellectis Products, Services and Solutions
5.8.4 Cellectis Revenue (US$ Million) (2015-2020)
5.8.5 Cellectis Recent Development and Reaction to Covid-19
5.9 Bellicum
5.9.1 Bellicum Profile
5.9.2 Bellicum Main Business and Company’s Total Revenue
5.9.3 Bellicum Products, Services and Solutions
5.9.4 Bellicum Revenue (US$ Million) (2015-2020)
5.9.5 Bellicum Recent Development and Reaction to Covid-19
5.10 Mustang Bio
5.10.1 Mustang Bio Profile
5.10.2 Mustang Bio Main Business and Company’s Total Revenue
5.10.3 Mustang Bio Products, Services and Solutions
5.10.4 Mustang Bio Revenue (US$ Million) (2015-2020)
5.10.5 Mustang Bio Recent Development and Reaction to Covid-19
5.11 CARsgen Therapeutics
5.11.1 CARsgen Therapeutics Profile
5.11.2 CARsgen Therapeutics Main Business and Company’s Total Revenue
5.11.3 CARsgen Therapeutics Products, Services and Solutions
5.11.4 CARsgen Therapeutics Revenue (US$ Million) (2015-2020)
5.11.5 CARsgen Therapeutics Recent Development and Reaction to Covid-19
5.12 Xyphos
5.12.1 Xyphos Profile
5.12.2 Xyphos Main Business and Company’s Total Revenue
5.12.3 Xyphos Products, Services and Solutions
5.12.4 Xyphos Revenue (US$ Million) (2015-2020)
5.12.5 Xyphos Recent Development and Reaction to Covid-19
5.13 Minerva Biotechnologies
5.13.1 Minerva Biotechnologies Profile
5.13.2 Minerva Biotechnologies Main Business and Company’s Total Revenue
5.13.3 Minerva Biotechnologies Products, Services and Solutions
5.13.4 Minerva Biotechnologies Revenue (US$ Million) (2015-2020)
5.13.5 Minerva Biotechnologies Recent Development and Reaction to Covid-19
5.14 Adaptimmune
5.14.1 Adaptimmune Profile
5.14.2 Adaptimmune Main Business and Company’s Total Revenue
5.14.3 Adaptimmune Products, Services and Solutions
5.14.4 Adaptimmune Revenue (US$ Million) (2015-2020)
5.14.5 Adaptimmune Recent Development and Reaction to Covid-19
5.15 Ziopharm Oncology
5.15.1 Ziopharm Oncology Profile
5.15.2 Ziopharm Oncology Main Business and Company’s Total Revenue
5.15.3 Ziopharm Oncology Products, Services and Solutions
5.15.4 Ziopharm Oncology Revenue (US$ Million) (2015-2020)
5.15.5 Ziopharm Oncology Recent Development and Reaction to Covid-19
5.16 Aurora Biopharma
5.16.1 Aurora Biopharma Profile
5.16.2 Aurora Biopharma Main Business and Company’s Total Revenue
5.16.3 Aurora Biopharma Products, Services and Solutions
5.16.4 Aurora Biopharma Revenue (US$ Million) (2015-2020)
5.16.5 Aurora Biopharma Recent Development and Reaction to Covid-19
5.17 Creative Biolabs
5.17.1 Creative Biolabs Profile
5.17.2 Creative Biolabs Main Business and Company’s Total Revenue
5.17.3 Creative Biolabs Products, Services and Solutions
5.17.4 Creative Biolabs Revenue (US$ Million) (2015-2020)
5.17.5 Creative Biolabs Recent Development and Reaction to Covid-19
6 North America CAR T-Cell Immunotherapy by Players and by Application
6.1 North America CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
6.2 North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
7 Europe CAR T-Cell Immunotherapy by Players and by Application
7.1 Europe CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
8 China CAR T-Cell Immunotherapy by Players and by Application
8.1 China CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
8.2 China CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
9 Rest of Asia Pacific CAR T-Cell Immunotherapy by Players and by Application
9.1 Rest of Asia Pacific CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
10 Latin America CAR T-Cell Immunotherapy by Players and by Application
10.1 Latin America CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
10.2 Latin America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
11 Middle East & Africa CAR T-Cell Immunotherapy by Players and by Application
11.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
12 CAR T-Cell Immunotherapy Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
